The isolated prolonged PTT

American Journal of Hematology

Volumn 88, Issue 1, 2013, Pages 82-85

  Tcherniantchouk, Oxana ^a   Laposata, Michael ^b   Marques, Marisa B ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPARIN; LUPUS ANTICOAGULANT; VON WILLEBRAND FACTOR;

ALGORITHM; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD SAMPLING; FOLLOW UP; GENETIC SCREENING; HEALTH CARE COST; HEMATOMA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HYPERCOAGULABILITY; MEDICAL PRACTICE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; THROMBOPLASTIN TIME; VON WILLEBRAND DISEASE;

ALGORITHMS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME;

EID: 84871421741     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23285     Document Type: Article

References (22)

1. Medical Professionalism Project. Medical professionalism in the new millennium: A physicians' charter. Ann Intern Med 2002; 136: 243-246.
2. Panteghini M. The future of laboratory medicine: Understanding the new pressures. Clin Biochem Rev 2004; 25: 207-215.
3. Blanckaert N. Clinical pathology services: Remapping our strategic itinerary. Clin Chem Lab Med 2010; 48: 919-925.
4. John WG, Nordin G, Panteghini M. What's in a name? Standardisation of HbA(1c): A response. Clin Chem Lab Med 2008; 46: 1326-1327.
5. Fritsma GA, Marques MB. The top ten problems in coagulation. Adv Admin Lab 2004; 16: 22-28.
6. Dighe AS, Soderberg BL, Laposata M. Narrative interpretations for clinical laboratory evaluations: An overview. Am J Clin Pathol 2001; 116: S123-S128.
7. Dowd MD, Sharma V. Questioning dogma: Is this test needed? Arch Pediatr Adolesc Med 2003; 157: 1157-1158.
8. Rothschild J. Computerized physician order entry in the critical care and general inpatient setting: A narrative review. J Crit Care 2004; 19: 271-278.
9. Howanitz PJ. Errors in laboratory medicine: Practical lessons to improve patient safety. Arch Pathol Lab Med 2005; 129: 1252-1261.
10. Laposata M, Dighe A. "Pre-pre" and "post-post" analytical error: High-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 2007; 45: 712-719.
11. Van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van Behmel JH. Compliance of general practitioners with guideline-based decision support system for ordering blood tests. Clin Chem 2002; 48: 55-60.
12. Shaneyfelt TM, Centor RM. Reassessment of clinical practice guidelines: Go gently into that good night. JAMA 2009; 301: 868-869.
13. Lomotan EA, Michel G, Lin Z, Shiffman RN. How "should" we write guideline recommendations? Interpretation of deontic terminology in clinical practice guidelines: Survey of the health services community. Qual Saf Health Care 2010; 19: 509-513.
14. Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clin Lab Med 2009; 29: 339-366.
15. Nichols WL, Rick ME, Ortel TL, et al. Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol 2009; 84: 366-370.
16. Conaglen PJ, Akowuah E, Theodore S, Atkinson V. Implications for cardiac surgery in patients with factor XII deficiency. Ann Thorac Surg 2010; 89: 625-626.
17. Shander A, Walsh CE, Cromwell C. Acquired hemophilia: A rare but life-threatening potential cause of bleeding in the intensive care unit. Intensive Care Med 2011; 37: 1240-1249.
18. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
19. Smock KJ, Rodgers GM. Laboratory identification of lupus anticoagulants. Am J Hematol 2009; 84: 440-442.
20. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
21. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
22. Hernandez JS. Cost-effectiveness of laboratory testing. Arch Path Lab Med 2003; 127: 440-445.